BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1723824)

  • 1. [Specific brain antigens as the indicators of the blood-brain barrier permeability in Alzheimer's disease].
    Groppa SA; Chekhonin VP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(9):50-2. PubMed ID: 1723824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunoenzyme detection of specific brain antigens as a criterion of the permeability of the hemato-encephalic barrier in rats following acute gamma irradiation].
    Chekhonin VP; Morozov GV; Riabukhin IA
    Biull Eksp Biol Med; 1989 Apr; 107(4):464-6. PubMed ID: 2470443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunoenzymatic detection of specific brain antigens as a criterion of the permeation of blood-brain barrier in rats with acute cerebral ischemia].
    Chekhonin VP; Morozov GV; Markovkin VM; Blizniukova AS
    Biull Eksp Biol Med; 1988 May; 105(5):581-3. PubMed ID: 2454685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immunity in brain aging and Alzheimer's disease.
    Bouras C; Riederer BM; Kövari E; Hof PR; Giannakopoulos P
    Brain Res Brain Res Rev; 2005 Jun; 48(3):477-87. PubMed ID: 15914253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Permeability of the hemato-encephalic barrier in critical states due to febrile schizophrenia].
    Morozov GV; Morkovkin VM; Chekhonin VP; Kekelidze ZI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(5):107-9. PubMed ID: 3137751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.
    Poduslo JF; Curran GL; Wengenack TM; Malester B; Duff K
    Neurobiol Dis; 2001 Aug; 8(4):555-67. PubMed ID: 11493021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-brain barrier permeability correlates with medial temporal lobe atrophy but not with amyloid-beta protein transport across the blood-brain barrier in Alzheimer's disease.
    Matsumoto Y; Yanase D; Noguchi-Shinohara M; Ono K; Yoshita M; Yamada M
    Dement Geriatr Cogn Disord; 2007; 23(4):241-5. PubMed ID: 17310121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Solid-phase immunosorption of antibodies against specific brain antigen from the blood of rats with experimental break of the blood-brain barrier].
    Chekhonin VP; Morozov GV; Cherkasova TA; Leĭkin IuA
    Dokl Akad Nauk SSSR; 1988; 302(6):1511-3. PubMed ID: 2466629
    [No Abstract]   [Full Text] [Related]  

  • 9. Breakdown of the blood brain barrier and blood-cerebrospinal fluid barrier is associated with differential leukocyte migration in distinct compartments of the CNS during the course of murine NCC.
    Alvarez JI; Teale JM
    J Neuroimmunol; 2006 Apr; 173(1-2):45-55. PubMed ID: 16406118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormalities of the glucose transporter at the blood-brain barrier and in brain in Alzheimer's disease.
    Kalaria RN; Harik SI
    Prog Clin Biol Res; 1989; 317():415-21. PubMed ID: 2602426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Specific brain antigens--an index of the permeability of the hemato-encephalic barrier in comatose states in children].
    Lidzhieva RTs; Berestov AI; Chekhonin VP; Blokhin BM; Korobko LM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(8):25-8. PubMed ID: 2461625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases.
    Stolp HB; Dziegielewska KM
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):132-46. PubMed ID: 19077110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The immunoenzyme analysis of the specific alpha2-glycoprotein in the brain in patients with neuropsychic diseases].
    Chekhonin VP; Koroteeva EA; Groppa SA; Bulaeva NV; Abashidze AI; Morozov SG
    Lab Delo; 1991; (8):37-42. PubMed ID: 1724505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum autoantibodies against glial fibrillary acidic protein in brain aging and senile dementias.
    Mecocci P; Parnetti L; Donato R; Santucci C; Santucci A; Cadini D; Foà E; Cecchetti R; Senin U
    Brain Behav Immun; 1992 Sep; 6(3):286-92. PubMed ID: 1392102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease: the proteoglycans hypothesis.
    Celesia GG
    Semin Thromb Hemost; 1991; 17 Suppl 2():158-60. PubMed ID: 1948087
    [No Abstract]   [Full Text] [Related]  

  • 16. [Permeability of the blood-brain barrier in severe craniocerebral trauma].
    Churliaev IuA; Nikiforova NV; Shukevich DL; Lykova OF; Konysheva TV; Bykov KV
    Anesteziol Reanimatol; 2002; (6):17-9. PubMed ID: 12611150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alzheimer's disease--considerations on the etiology and physiopathology based on a case report].
    Johansen LH
    Ugeskr Laeger; 1991 Apr; 153(14):1001-2. PubMed ID: 2024309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological and biochemical alterations of astrocytes in ovariectomized rats injected with D-galactose: a potential contribution to Alzheimer's disease processes.
    Hua X; Lei M; Ding J; Han Q; Hu G; Xiao M
    Exp Neurol; 2008 Apr; 210(2):709-18. PubMed ID: 18289535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Protective reaction of brain cells during change in permeability of the blood-brain barrier].
    Khokhlov AP; Fetisova IG; Podlesnyĭ AM; Chekhonin VP; Malakhovskiĭ VK
    Vopr Med Khim; 1993; 39(4):25-7. PubMed ID: 8379108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term changes in blood-brain barrier permeability and white matter following prolonged systemic inflammation in early development in the rat.
    Stolp HB; Dziegielewska KM; Ek CJ; Potter AM; Saunders NR
    Eur J Neurosci; 2005 Dec; 22(11):2805-16. PubMed ID: 16324115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.